October 2, 2026 – Johns Hopkins Medicine researchers have identified a genome-level checkpoint that helps macrophages, which are immune cells that respond to infection, injury and tissue damage, remain” ready for action without becoming prematurely inflammatory or hyperinflammatory,” according to a prepared statement. The study was led by Dr. Laszlo Nagy, who is the co-director of the Johns Hopkins All Children’s Institute for Fundamental Biomedical Research in St. Petersburg. For more information, visit this link.
